COVID-19 Pandemic Had Little Or No Impact On New Malignant Mesothelioma Diagnoses
A new study published in Thoracic Cancer discussed the impact of COVID‐19 pandemic on new mesothelioma diagnoses in Italy. Malignant mesothelioma is a rare disease of great interest to the scientific community and to public health. This is due to its high lethality and its association with asbestos exposure. The timely diagnosis of mesothelioma is important. Although it may not change the prognosis of the disease, it can help in treatment strategies. It can also help in documenting previous exposure to asbestos. This can contribute to any request for compensation. New Study Shows Promising Results During the COVID-19 pandemic, there was a delay in the diagnosis of oncological diseases. This was because many departments were converted into COVID wards. And…